Pharmaceutical company Eli Lilly wants deal to bring Mounjaro to Australia under PBS | 7.30
Community Score: 50% | 1.3K views | 4d
0 community ratings: null thumbs up, null thumbs down
They're the wonder drugs of our age - the GLP-1 inhibitors like Ozempic and Mounjaro - that have revolutionised the treatment of diabetes and obesity worldwide. Earlier this year the manufacturer of one of those drugs - Mounjaro owner Eli Lilly - walked away from negotiations with Australia's PBS, claiming Australia wasn't offering enough money. According to Eli Lilly, the PBS is the problem - out of step with modern drug development. But also part of the story: a Donald Trump executive order forcing US pharmaceutical companies to offer the same price on prescription drugs to Americans as consumers pay in countries like Australia. 7.30’s Sarah Ferguson interviews David Ricks, the CEO of Eli Lilly, the world's first trillion-dollar drug company. Subscribe: https://ab.co/3yqPOZ5 Read more here: https://www.abc.net.au/news/2026-08-12/eli-lillyceo-still-looking-to-bring-mounjaro-to-australia/107030066 Welcome to ABC News In-depth, where you'll find our long-form journalism and oth
Tags: abc news, australian news, abc news indepth, documentaries, long-form journalism, Mounjaro, Ozempic, GLP-1 inhibitors, Eli Lilly, pbs, David Ricks, pharmaceutical, drugs, australia, donald trump, medication
More from ABC News In-depth
- Epstein Files: Allegations Trump committed "serious crimes" says Congressman | Planet America — Score: 50%
- The toxic threat posed by Antarctica's frozen 'ghost town' | 7.30 — Score: 50%
- ICE op ends, Trump polls hits new low #planetamerica #Minnesota #trumpimmigration — Score: 50%
- Is the US close to attacking Iran? | ABC News Verify — Score: 50%
- Scientists are on the brink of a breakthrough in sepsis treatment | 7.30 — Score: 50%
- Copper theft is costing taxpayers millions of dollars every year | 7.30 — Score: 50%